The Promoter of the Immunoglobulin J Chain Gene Receives Its Authentic Enhancer Activity through the Abutting MEF2 and PU.1 Sites in a DNA-Looping Interaction

Journal of Molecular Biology

Volumn 390, Issue 3, 2009, Pages 339-352

  Lim, Jung Hyun ^a   Kim, Hong Gi ^a   Park, Sung Kyun ^a   Kang, Chang Joong ^a  

^a Kyung Hee University   (South Korea)

Author keywords

DNA looping; IgJ enhancer; IgJ promoter; MEF2; PU.1

Indexed keywords

IMMUNOGLOBULIN J CHAIN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; UPSTREAM STIMULATORY FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BINDING SITE; CONTROLLED STUDY; DNA FOOTPRINTING; ENHANCER REGION; GENE INTERACTION; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION;

EID: 67549089478     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.05.040     Document Type: Article

References (37)

1. Koshland M.E. Presidential address: molecular aspects of B cell differentiation, American association of immunologists, April 1983. J. Immunol. 131 (1983) i-ix
2. Niles M.J., Matsuuchi L., and Koshland M.E. Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis. Proc. Natl. Acad. Sci. USA 92 (1995) 2884-2888
3. Johansen F.-E., Braathen R., and Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167 (2001) 5185-5192
4. Lansford R.D., McFadden H.J., Siu S.T., Cox J.S., Cann G.M., and Koshland M.E. A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene. Proc. Natl. Acad. Sci. USA 89 (1992) 5966-5970
5. Kang C.-J., Sheridan C., and Koshland M.E. A stage-specific enhancer of immunoglobulin J chain gene is induced by interleukin-2 in a presecretor B cell stage. Immunity 8 (1998) 285-295
6. Artandi S.E., Cooper C., Shrivastava A., and Calame K. The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction. Mol. Cell. Biol. 14 (1994) 7704-7716
7. Langdon S.D., and Kaufman R.E. Gamma-globin gene promoter elements required for interaction with globin enhancers. Blood 91 (1998) 309-318
8. McDowell J.C., and Dean A. Structural and functional cross-talk between a distant enhancer and the e{open}-globin gene promoter shows interdependence of the two elements in chromatin. Mol. Cell. Biol. 19 (1999) 7600-7609
9. Carey M. The enhanceosome and transcriptional synergy. Cell 92 (1998) 5-8
10. Shin M.K., and Koshland M.E. Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev. 7 (1993) 2006-2015
11. Rinkenberger J.L., Wallin J.J., Johnson K.W., and Koshland M.E. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5 (1996) 377-386
12. Wallin J.J., Gackstetter E.R., and Koshland M.E. Dependence of BSAP repressor and activator functions on BSAP concentration. Science 279 (1998) 1961-1964
13. Wallin J.J., Rinkenberger J.L., Rao S., Gackstetter E.R., Koshland M.E., and Zwollo P. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J. Biol. Chem. 274 (1999) 15959-15965
14. Rao S., Karray S., Gackstetter E.R., and Koshland M.E. Myocyte enhancer factor-regulated B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J. Biol. Chem. 273 (1998) 26123-26129
15. McFadden H.J., and Koshland M.E. Interleukin 2- and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter. Proc. Natl. Acad. Sci. USA 88 (1991) 11027-11031
16. Matsuuchi L., Cann G.M., and Koshland M.E. Immunoglobulin J chain gene from the mouse. Proc. Natl. Acad. Sci. USA 83 (1986) 456-460
17. Rippe K., von Hippel P.H., and Langowski J. Action at a distance: DNA-looping and initiation of transcription. Trends Biochem. Sci. 20 (1995) 500-506
18. Blackwood E.M., and Kadonaga J.T. Going the distance: a current view of enhancer action. Science 281 (1998) 60-63
19. Tolhuis B., Palstra R.-J., Splinter E., Grosveld F., and de Laat W. Looping and interaction between hypersensitive sites in the active β-globin locus. Mol. Cell 10 (2002) 1453-1465
20. Hatzis P., and Talianidis I. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10 (2002) 1467-1477
21. Lim J.-H., Cho S.-J., Park S.-K., Kim J., Cho D., Lee W.J., et al. Stage-specific expression of two neighboring Crlz1 and IgJ genes during B cell development is regulated by their chromatin accessibility and histone acetylation. J. Immunol. 177 (2006) 5420-5429
22. Tierney R., Nagra J., Hutchings I., Shannon-Lowe C., Altmann M., Hammerschmidt W., et al. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program. J. Virol. 81 (2007) 10092-10100
23. Bulger M., and Groudine M. Looping versus linking: toward a model for long-distance gene activation. Genes Dev. 13 (1999) 2465-2477
24. Engel J.D., and Tanimoto K. Looping, linking, and chromatin activity: new insights into β-globin locus regulation. Cell 100 (2000) 499-502
25. Staudt L.M., and Lenardo M.J. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9 (1991) 373-398
26. Erman B., Cortes M., Nikolajczyk B.S., Speck N.A., and Sen R. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol. Cell. Biol. 18 (1998) 1322-1330
27. Kozmik Z., Wang S., Dorfler P., Adams B., and Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12 (1992) 2662-2672
28. Walter K., Bonifer C., and Tagoh H. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 112 (2008) 1673-1682
29. Wang J.C., and Giaever G.N. Action at a distance along a DNA. Science 240 (1988) 300-304
30. Dekker J., Rippe K., Dekker M., and Kleckner N. Capturing chromosome conformation. Science 295 (2002) 1306-1311
31. Blackman M.A., Tigges M.A., Minie M.E., and Koshland M.E. A model system for peptide hormone action in differentiation: interleukin 2 induces a B lymphoma to transcribe the J chain gene. Cell 47 (1986) 609-617
32. Black B.L., Ligon K.L., Zhang Y., and Olson E.N. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family. J. Biol. Chem. 271 (1996) 26659-26663
33. Molkentin J.D., Black B.L., Martin J.F., and Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83 (1995) 1125-1136
34. Wilker P.R., Kohyama M., Sandau M.M., Albring J.C., Nakagawa O., Schwarz J.J., et al. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat. Immunol. 9 (2008) 603-612
35. Sigvardsson M., O'Riordan M., and Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7 (1997) 25-36
36. Hesse J.E., Lieber M.R., Gellert M., and Mizuuchi K. Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals. Cell 49 (1987) 775-783
37. Kim J.-Y., Park S.-K., Kim H.-G., Cho S.-J., Kim J., and Kang C.-J. The HSS3/4 enhancer of Crlz1-IgJ locus is another target of EBF in the pre-B cell stage of B cell development. Immunol. Lett. 107 (2006) 63-70